首页> 外文OA文献 >Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group Study

【2h】

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group Study

机译：乙草胺酯与甲氨蝶呤在头颈部转移性和/或复发性鳞状细胞癌患者中的III期随机试验：欧洲癌症头颈部癌研究与治疗组织合作研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Schornagel J.H.; Verweij J.; Mulder P.H.M. de; Cognetti F.; Vermorken J.B.; Cappelaere P.; Armand J.P.; Wildiers J.; Graeff A. de; Clavel M.; Sahmoud T.; Kirkpatrick A.; Lefebvre J.L.;
展开▼
作者单位

展开▼
年度 1995
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy [J] . Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, BMC Cancer . 2014,第1期

机译：LUX-Head＆Neck的原理和设计1：阿法替尼与甲氨蝶呤在铂类药物治疗后复发和/或转移性头颈部鳞状细胞癌患者中进行的一项随机，III期临床试验
2. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy [J] . Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, BMC Cancer . 2014,第1期

机译：LUX-Head＆Neck的原理和设计1：阿法替尼与甲氨蝶呤在铂类药物治疗后复发和/或转移性头颈部鳞状细胞癌患者中进行的一项随机，III期临床试验
3. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial [J] . Machiels Jean-Pascal H., Haddad Robert I., Fayette Jerome, The lancet oncology . 2015,第5期

机译：阿法替尼vs甲氨蝶呤作为铂类疗法治疗后或复发的复发性或转移性头颈部鳞状细胞癌患者的二线治疗（LUX-Head＆Neck 1）：一项开放性，随机，3期试验
4. Survival prediction of squamous cell head and neck cancer patients based on radiomic features selected from lung cancer patients using artificial neural network [C] . H. Kamezawa, H. Arimura, M. Soufi SPIE Medical Imaging Conference . 2018

机译：利用人工神经网络从肺癌患者的放射学特征中预测鳞状细胞癌的生存率
5. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. [D] . 野﨑, 結 2019

机译：PD-L1特异性辅助性T细胞表现出有效的抗肿瘤反应：针对头颈部鳞状细胞癌中PD-L1的癌症免疫疗法的新策略。
6. Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head Neck 3): an open-label randomised phase III trial [O] . Y Guo, M -J Ahn, A Chan, -1

机译：阿法替尼与甲氨蝶呤作为亚洲复发或转移性鳞状鳞癌的亚洲患者二线治疗在铂类疗法治疗之后或之后进行（LUX-Head＆Neck 3）：一项开放性随机III期试验
7. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study. [O] . J H Schornagel, J Verweij, P H de Mulder, 1995

机译：乙草胺酯与甲氨蝶呤在头颈部转移性和/或复发性鳞状细胞癌患者中的III期随机试验：欧洲癌症头颈部癌研究与治疗组织合作研究

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group Study

著录项

引文网络

相似文献

相关主题

期刊订阅